Biotech Values

[10nisman]

Ernst & Young Entrepreneur Award is B.S

Obviously. It's a great way for E&Y to reward certain clients for paying their audit/tax fees on time.

I am not saying wheeler is like that...But since he became CEO in 2006, not a lot has happened from business standpoint(besides lovenox which is huge)...Of course internally they are continuing to make progress on copaxone and building IP for FOB. That's why I said, the FOB partnership is a real test for wheeler I think he will deliver for shareholders

Not a lot has happened? Ridiculous comment.